MET (956-end), active, GST tagged human, PRECISIO Kinase, recombinant, expressed in baculovirus infected Sf9 cells, >=70% (SDS-PAGE), buffered aqueous glycerol solution

Code: m0574-10ug D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

MET is a proto-oncogene that encodes a transmembrane growth factor receptor which is a heterodimer of two disulfide linked chains of 50 kDa (alpha) an...


read more

Your Price
$542.10 10UG

Not available outside of the UK & Ireland.

Biochem/physiol Actions

MET is a proto-oncogene that encodes a transmembrane growth factor receptor which is a heterodimer of two disulfide linked chains of 50 kDa (alpha) and 145 kDa (beta). MET is widely expressed in the kidney, brain, lung, skin, and embryonic tissue. Hepatocyte growth factor (HGF) binds to MET and activates its tyrosine kinase activity. MET is overexpressed and activated in a variety of human cancers including pancreatic, colon, gastric, cervical and ovariancancers and has been shown to be involved in tumor cell migration and invasion.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM Tris-HCl, pH 7.5, with 150 mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... MET(4233)
mol wt~81 kDa
product linePRECISIO® Kinase
Quality Level200
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity37-55 nmol/min·mg
storage temp.−70°C
UniProt accession no.P08581
This product has met the following criteria: